Nima Ghamsari, an officer and director of Blend Labs, Inc., filed a Form 144 notice of proposed sale on November 2, 2026, covering 22,322 shares of Blend Labs common stock with an aggregate market value of $25,784.00.

Key Highlights

  • Proposed sale: Ghamsari intends to sell 22,322 shares of Blend Labs common stock through Charles Schwab & Co., Inc., with an approximate sale date of November 2, 2026.
  • Aggregate market value: The filing reports an aggregate market value of $25,784.00 for the shares to be sold.
  • Source of shares: The 22,322 shares were acquired on November 20, 2025, via a restricted stock lapse from Blend Labs, Inc., with payment characterized as equity compensation.
  • Shares outstanding: According to the filing, there were 233,256,934 shares of Blend Labs common stock outstanding at the time of the notice.
  • Rule 10b5-1 plan: The filing indicates a trading plan adoption date of June 15, 2026, suggesting reliance on a Rule 10b5-1 plan.
  • Recent prior sales: The filing discloses seven sales by Ghamsari in the prior three months, ranging from 17,731 to 27,775 shares per transaction, between September 14, 2026, and October 26, 2026.

Ghamsari's Proposed Sale and Prior Transaction History at Blend Labs

According to the filing, Nima Ghamsari, who is identified as both an officer and a director of Blend Labs, Inc. (NYSE:BLND), submitted a Form 144 notice dated November 2, 2026, for the proposed sale of 22,322 shares of Blend Labs common stock. The shares are to be sold through Charles Schwab & Co., Inc., located in Westlake, Texas. The filing reports the aggregate market value of the shares at $25,784.00.

The filing discloses that the 22,322 shares subject to the proposed sale were acquired on November 20, 2025, through a restricted stock lapse transaction from Blend Labs, Inc., with the nature of payment listed as equity compensation. The filing also notes a Rule 10b5-1 plan adoption date of June 15, 2026, which the filing indicates is the basis for the trading instruction underlying the proposed sale.

In the three-month period preceding the notice, the filing reports that Ghamsari sold Blend Labs shares on seven separate dates: 17,731 shares on September 14, 2026 (gross proceeds $25,267.00); 21,009 shares on September 21, 2026 (gross proceeds $25,024.00); 22,523 shares on September 28, 2026 (gross proceeds $24,816.00); 24,272 shares on October 5, 2026 (gross proceeds $24,649.00); 25,098 shares on October 12, 2026 (gross proceeds $24,474.00); 27,775 shares on October 19, 2026 (gross proceeds $25,676.00); and 21,368 shares on October 26, 2026 (gross proceeds $23,903.00). All prior sales are attributed to Nima Ghamsari at the Novato, California address listed in the filing.

What Was Disclosed

Blend Labs officer and director Nima Ghamsari filed a Form 144 on November 2, 2026, disclosing a proposed sale of 22,322 common shares valued at $25,784.00, acquired via a November 2025 restricted stock lapse, with seven additional sales reported in the prior three months.